Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Association of early-onset androgenetic alopecia and metabolic syndrome in Thai men: a case-control study.

Pengsalae N, Tanglertsampan C, Phichawong T, Lee S.

J Med Assoc Thai. 2013 Aug;96(8):947-51.

PMID:
23991602
2.

Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study.

Arias-Santiago S, Gutiérrez-Salmerón MT, Castellote-Caballero L, Buendía-Eisman A, Naranjo-Sintes R.

J Am Acad Dermatol. 2010 Sep;63(3):420-9. doi: 10.1016/j.jaad.2009.10.018. Epub 2010 Jul 8.

PMID:
20619491
3.

The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia.

Mumcuoglu C, Ekmekci TR, Ucak S.

Eur J Dermatol. 2011 Jan-Feb;21(1):79-82. doi: 10.1684/ejd.2010.1193.

PMID:
21224180
4.

[Male androgenetic alopecia and cardiovascular risk factors: A case-control study].

Arias-Santiago S, Gutiérrez-Salmerón MT, Castellote-Caballero L, Buendía-Eisman A, Naranjo-Sintes R.

Actas Dermosifiliogr. 2010 Apr;101(3):248-56. Spanish.

PMID:
20398601
5.

Higher body mass index is associated with greater severity of alopecia in men with male-pattern androgenetic alopecia in Taiwan: a cross-sectional study.

Yang CC, Hsieh FN, Lin LY, Hsu CK, Sheu HM, Chen W.

J Am Acad Dermatol. 2014 Feb;70(2):297-302.e1. doi: 10.1016/j.jaad.2013.09.036. Epub 2013 Nov 1.

PMID:
24184140
6.

Early onset of androgenetic alopecia associated with early severe coronary heart disease: a population-based, case-control study.

Matilainen VA, Mäkinen PK, Keinänen-Kiukaanniemi SM.

J Cardiovasc Risk. 2001 Jun;8(3):147-51.

PMID:
11455846
7.

Association of androgenetic alopecia with metabolic syndrome in men: a community-based survey.

Su LH, Chen TH.

Br J Dermatol. 2010 Aug;163(2):371-7. doi: 10.1111/j.1365-2133.2010.09816.x. Epub 2010 Apr 23.

PMID:
20426781
8.

[Association between androgenetic alopecia and metabolic syndrome: a meta-analysis].

Wu DX, Wu LF, Yang ZX.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2014 Sep;43(5):597-601. Chinese.

PMID:
25372648
9.

Androgenetic alopecia as an early marker of benign prostatic hyperplasia.

Arias-Santiago S, Arrabal-Polo MA, Buendía-Eisman A, Arrabal-Martín M, Gutiérrez-Salmerón MT, Girón-Prieto MS, Jimenez-Pacheco A, Calonje JE, Naranjo-Sintes R, Zuluaga-Gomez A, Serrano Ortega S.

J Am Acad Dermatol. 2012 Mar;66(3):401-8. doi: 10.1016/j.jaad.2010.12.023. Epub 2011 Aug 11.

PMID:
21835498
10.

Gender-specific association of androgenetic alopecia with metabolic syndrome in a middle-aged Korean population.

Yi SM, Son SW, Lee KG, Kim SH, Lee SK, Cho ER, Kim IH, Shin C.

Br J Dermatol. 2012 Aug;167(2):306-13. doi: 10.1111/j.1365-2133.2012.10978.x. Epub 2012 Jul 5.

PMID:
22486172
11.

Androgenetic alopecia as an indicator of metabolic syndrome and cardiovascular risk.

Ertas R, Orscelik O, Kartal D, Dogan A, Ertas SK, Aydogdu EG, Ascioglu O, Borlu M.

Blood Press. 2016 Jun;25(3):141-8. doi: 10.3109/08037051.2015.1111021. Epub 2015 Nov 20.

PMID:
26585114
12.
13.

Risk factors for male lower urinary tract symptoms: the role of metabolic syndrome and androgenetic alopecia in a Latin American population.

Barbosa JA, Muracca E, Nakano E, Paranhos M, Natalino R, Cordeiro P, Srougi M, Antunes AA.

Urology. 2013 Jul;82(1):182-8. doi: 10.1016/j.urology.2013.03.001. Epub 2013 May 1.

PMID:
23642850
14.

Severe androgenetic alopecia as a proxy of metabolic syndrome in male psoriatic patients older than 59 years.

Descamps V, Mahé E, Maccari F, Begon E, Barthelemy H, Reguiai Z, Bénéton N, Estève E, Chaby G, Ruer-Mulard M, Steiner HG, Thomas-Beaulieu D, Avenel-Audran M, Goujon-Henry C, Sigal ML, Ezzedine K, Beauchet A; Groupe d’Etudes Multicentriques RESOPSO..

Eur J Dermatol. 2014 May-Jun;24(3):356-60. doi: 10.1684/ejd.2014.2346.

PMID:
24979347
15.

Androgenetic alopecia and insulin resistance: are they truly associated?

Abdel Fattah NS, Darwish YW.

Int J Dermatol. 2011 Apr;50(4):417-22. doi: 10.1111/j.1365-4632.2010.04677.x.

PMID:
21413951
16.

Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors.

Severi G, Sinclair R, Hopper JL, English DR, McCredie MR, Boyle P, Giles GG.

Br J Dermatol. 2003 Dec;149(6):1207-13.

PMID:
14674898
17.

Androgenetic alopecia and risk of prostate cancer: a systematic review and meta-analysis.

Amoretti A, Laydner H, Bergfeld W.

J Am Acad Dermatol. 2013 Jun;68(6):937-43. doi: 10.1016/j.jaad.2012.11.034. Epub 2013 Feb 8. Review.

PMID:
23395589
18.

Androgenetic alopecia and insulin resistance in young men.

González-González JG, Mancillas-Adame LG, Fernández-Reyes M, Gómez-Flores M, Lavalle-González FJ, Ocampo-Candiani J, Villarreal-Pérez JZ.

Clin Endocrinol (Oxf). 2009 Oct;71(4):494-9. doi: 10.1111/j.1365-2265.2008.03508.x.

PMID:
19094069
19.

Association of androgenetic alopecia with mortality from diabetes mellitus and heart disease.

Su LH, Chen LS, Lin SC, Chen HH.

JAMA Dermatol. 2013 May;149(5):601-6. doi: 10.1001/jamadermatol.2013.130.

PMID:
23677087
20.

Patients with a large prostate show a higher prevalence of androgenetic alopecia.

Chen W, Yang CC, Chen GY, Wu MC, Sheu HM, Tzai TS.

Arch Dermatol Res. 2004 Nov;296(6):245-9. Erratum in: Arch Dermatol Res. 2005 Oct;297(4):184.

PMID:
15517324

Supplemental Content

Support Center